je.st
news
Tag: meeting
Protesters again disrupt Portland City Council meeting
2015-05-14 18:24:01| PortlandOnline
Brad Schmidt in The Oregonian, May 13, 2015
Tags: city
meeting
council
portland
Eisai to Present New Research on Oncology Products and Pipeline at 51st ASCO Annual Meeting
2015-05-14 14:35:07| Logistics - Topix.net
Highlights Include New Clinical Data on Halaven in Soft Tissue Sarcoma and on Lenvima in Renal Cell Carcinoma TOKYO, May 14, 2015 - - Eisai Co., Ltd. announced today that a series of abstracts highlighting new study results on Halaven and Lenvima with a novel binding mode, "lenvatinib") will be presented during the 51st Annual Meeting of the American Society of Clinical Oncology , taking place in Chicago, the United States, from May 29 to June 2, 2015.
Tags: products
research
present
meeting
Clovis Oncology Announces Data Presentations at 2015 ASCO Annual Meeting
2015-05-14 10:21:11| Logistics - Topix.net
Clovis Oncology today announced that two oral presentations and six poster sessions highlighting updated results and trial designs from clinical studies of the company's three compounds in advanced clinical development are being presented at the 2015 American Society of Clinical Oncology Annual Meeting, which will take place May 29-June 2, 2015 in Chicago.
Tags: data
meeting
annual
presentations
2015 ASCO Annual Meeting: New Data in 10 Different Cancers from Mercks Rapidly Expanding Immuno-Oncology Research Program for KEYTRUDA (pembrolizumab) to be Presented
2015-05-13 23:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. New Findings Show Anti-tumor Activity of KEYTRUDA in Five Additional Cancers: Colorectal, Esophageal, Ovarian, Renal Cell Carcinoma and Small-Cell Lung Cancer First-Time Presentations of DNA Mismatch Repair Deficiency Data in Colorectal and other Cancers and Nanostring RNA Data in Melanoma, Head and Neck and Gastric Cancers Industry-leading Number of PD-1 Clinical Trials Resulting in Growing Body of Data for KEYTRUDA across 13 Tumor Types KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that new investigational data in 10 different types of cancer from the companys immuno-oncology development program evaluating its anti-PD-1 therapy, KEYTRUDA (pembrolizumab), will be presented at the 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, May 29 June 2, 2015. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Claire Mulhearn, 908-236-1118orInvestors:Joseph Romanelli, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: to
data
research
program
Registration for ASLA Annual Meeting and EXPO is now open.
2015-05-13 14:31:06| Industrial Newsroom - All News for Today
Taking place November 6–9 in Chicago, ASLA's 2015 Annual Meeting & EXPO, themed "Perspectives," highlights comprehensive viewpoint that helps enable landscape architects to effectively solve today's complex planning and environmental design problems. More than 6,000 attendees are expected, and meeting will feature diverse spectrum of industry experts providing perspectives on wide range of subjects, from sustainable design to active living to best practices and new technologies.
Sites : [623] [624] [625] [626] [627] [628] [629] [630] [631] [632] [633] [634] [635] [636] [637] [638] [639] [640] [641] [642] next »